申请人:BAYER AG
公开号:WO2021074227A1
公开(公告)日:2021-04-22
The present invention covers 2-methyl-aza-quinazoline compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
本发明涵盖了一般式(I)所描述和定义的2-甲基-氮杂喹噁啉化合物,以及制备该化合物的方法,用于制备该化合物的有用中间体化合物,包含该化合物的药物组合物和药物组合物,以及利用该化合物制造用于治疗或预防疾病,特别是过度增殖性疾病的药物组合物的用途,作为唯一药剂或与其他活性成分组合使用。